[#item_full_content]
SAN FRANCISCO–(BUSINESS WIRE)– #AdjuviaTherapeutics–Adjuvia Therapeutics raises $8 million to advance ATI-105, a novel mitochondrial disease therapy, into Phase 1 clinical trials.
[#item_full_content]
SAN FRANCISCO–(BUSINESS WIRE)– #AdjuviaTherapeutics–Adjuvia Therapeutics raises $8 million to advance ATI-105, a novel mitochondrial disease therapy, into Phase 1 clinical trials.